BERGEM·HEALTH
Home Doctors Assoc. Prof. Kezban Nur Pilancı, MD
MEDICAL ONCOLOGY · MEMORIAL BAHÇELİEVLER

Assoc. Prof. Kezban Nur Pilancı, MD

Associate Professor of Medical Oncology · Memorial Bahçelievler Hospital
Assoc. Prof. Kezban Nur Pilancı is a medical oncologist at Memorial Bahçelievler Hospital, where she has practiced since 2018. She completed her medical degree at İstanbul University Cerrahpaşa Faculty of Medicine (2002), her internal medicine residency at Haseki Training & Research Hospital, and her medical oncology sub-specialty at Bilim University (2011-2014). Her clinical and research focus covers breast cancer (molecular subtyping, hormone receptor status), non-small cell lung cancer, colorectal cancer with brain metastases, genital and testicular cancers.
Specialties: Oncology
20+
years in oncology
7+
years at Memorial Bahçelievler
Breast CancerLung CancerColorectal CancerGenital CancersTesticular Cancer
A BergemHealth coordinator arranges contact with the professor within 24–48 hours on business days.
Direct contract with BergemHealth
CONSULTATION LANGUAGES
TR Turkish · native
EN English · professional
RU Russian · via BergemHealth coordinator
UK Ukrainian · via BergemHealth coordinator
ISTANBUL · 05/2026
EDUCATION & CAREER

Timeline

Career milestones.

2014-2018
Medical Oncology Specialist
various private hospitals (incl. Memorial Şişli per anatoliahealthtravel)
2018-Present
Medical Oncology Specialist
Memorial Bahçelievler Hospital + İstanbul Arel University Faculty of Medicine
PUBLICATIONS

Scientific work

Selected peer-reviewed publications.

  • 2015
    Diagn Interv Radiol
    «The role of ultrasonographic findings to predict molecular subtype, histologic grade, and hormone receptor status of breast cancer»
    · co-author · 112 citations
  • 2017
    Saudi Med J
    «Hormone receptor status and survival of medullary breast cancer patients: A Turkish cohort»
    · co-author · 23 citations
  • 2021
    Cancer Chemother Pharmacol
    «Efficacy and safety of trastuzumab emtansine in HER2 positive metastatic breast cancer: real-world experience»
    · co-author · 16 citations
  • 2014
    Asian Pac J Cancer Prev
    «Can megestrol acetate induce thrombosis in advanced oncology patients receiving chemotherapy»
    · co-author · 16 citations
  • 2018
    J Breast Cancer
    «Prognostic significance of adjuvant chemotherapy induced amenorrhea in luminal A and B subtypes»
    · co-author · 7 citations
  • 2023
    Curr Med Res Opin
    «Clinical and inflammation marker features of cancer patients with COVID-19: data of Istanbul, Turkey»
    · co-author · 7 citations
REQUEST

Tell me about your case — I’ll read it personally.

Fill in the short form on the consultation page — diagnosis, preferred timing, attached records. We assemble a tumour board for your case and reply within 4 hours.

Open the consultation form
  • Reply within 4 hours during business hours
  • Confidentiality guaranteed
  • Coordinator-translator inside the doctor’s office
  • Tumour board of 2–3 professors within 72 hours